July 30, 2015 /
Cambridge,
Massachusetts based Biogen Inc. has reported its second quarter 2015 results,
posting a year-over-year seven percent revenue increase to $2.6 Billion in the
quarter. “Biogen remains focused on improving the lives of people living with
complex diseases,” says Chief Executive Officer George A. Scangos, Ph.D.
“Tecfidera, which is now the most prescribed oral MS […]
Massachusetts based Biogen Inc. has reported its second quarter 2015 results,
posting a year-over-year seven percent revenue increase to $2.6 Billion in the
quarter. “Biogen remains focused on improving the lives of people living with
complex diseases,” says Chief Executive Officer George A. Scangos, Ph.D.
“Tecfidera, which is now the most prescribed oral MS […]
The post Biogen’s Tecfidera Now The Most Prescribed Oral MS
Therapy Globally appeared first on Multiple Sclerosis News Today.
Therapy Globally appeared first on Multiple Sclerosis News Today.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
.========================================================
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews
Stay informed with MS news and information - Sign-up here
For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY CHAT
